MILDRONATE 500mg capsules medication leaflet

C01EB22 meldoniu • Cardiovascular system | Other cardiac preparations

Meldonium is a medication used to improve physical performance and treat cardiovascular conditions such as angina and heart failure. It works by optimizing cellular metabolism and increasing oxygen flow to tissues.

The drug is commonly used in Eastern Europe and Central Asia but is not approved for use in many other countries. Meldonium is available in capsule or injectable solution form, and the dosage is adjusted based on the condition being treated.

Although considered safe at therapeutic doses, meldonium may cause side effects such as headaches, dizziness, nausea, or allergic reactions. Its use has been controversial in sports, as it has been banned by the World Anti-Doping Agency (WADA) since 2016.

Patients taking meldonium should be monitored by a doctor, especially if they have other chronic conditions or are taking additional medications. Pregnant or breastfeeding women should avoid using this medication without a specialist's recommendation.

General data about MILDRONATE 500mg

Substance: meldoniu

Date of last drug list: 01-06-2025

Commercial code: W68527002

Concentration: 500mg

Pharmaceutical form: capsules

Quantity: 60

Product type: generic

Price: 88.76 RON

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: AS GRINDEKS - LETONIA

Holder: AS GRINDEKS - LETONIA

Number: 14134/2021/02

Shelf life: 4 years

Pharmaceutical forms available for meldoniu

Concentrations available for meldoniu

500mg, 500mg/5ml